A Study to Evaluate the Long-term Safety and Efficacy of Deucravacitinib in Participants With Crohn's Disease or Ulcerative Colitis
Clinical trial NCT04877990 · COMPLETED
Trial details
- NCT number
- NCT04877990
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-07
- Primary completion
- 2023-08-29
- Enrollment
- 67
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.